Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom...
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
Stay updated with breaking news from Exploratory Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --
LA JOLLA, Calif., August 30, 2023--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th International Epilepsy Congress (IEC) and the American College of Clinical Pharmacology (ACCP) Annual Meeting.
30.08.2023 - Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th ... Seite 1
/PRNewswire/ -- HistoIndex, a global leading artificial intelligence (AI) digital pathology provider, has announced an agreement with clinical-stage...